A new ALK isoform transported by extracellular vesicles confers drug resistance to melanoma cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A new ALK isoform transported by extracellular vesicles confers drug resistance to melanoma cells
Authors
Keywords
-
Journal
Molecular Cancer
Volume 17, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-10-05
DOI
10.1186/s12943-018-0886-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cells
- (2017) Giulia Cesi et al. Molecular Cancer
- ALK Inhibitor Response in Melanomas Expressing EML4-ALK Fusions and Alternate ALK Isoforms
- (2017) Kasey L. Couts et al. MOLECULAR CANCER THERAPEUTICS
- Targeted agents and immunotherapies: optimizing outcomes in melanoma
- (2017) Jason J. Luke et al. Nature Reviews Clinical Oncology
- Compounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor Resistance
- (2016) Michaël Cerezo et al. CANCER CELL
- Communication by Extracellular Vesicles: Where We Are and Where We Need to Go
- (2016) Mercedes Tkach et al. CELL
- Transferring intercellular signals and traits between cancer cells: extracellular vesicles as “homing pigeons”
- (2016) Giulia Cesi et al. Cell Communication and Signaling
- Melanoma: the intersection of molecular targeted therapy and immune checkpoint inhibition
- (2016) Peter Kar Han Lau et al. CURRENT OPINION IN IMMUNOLOGY
- Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016
- (2016) Claus Garbe et al. EUROPEAN JOURNAL OF CANCER
- Combination dabrafenib and trametinib in the management of advanced melanoma with BRAFV600 mutations
- (2016) Lavinia Spain et al. EXPERT OPINION ON PHARMACOTHERAPY
- Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors
- (2016) Gao Zhang et al. JOURNAL OF CLINICAL INVESTIGATION
- Metastatic Melanoma: Insights Into the Evolution of the Treatments and Future Challenges
- (2016) Antoine Millet et al. MEDICINAL RESEARCH REVIEWS
- The Systemic Management of Advanced Melanoma in 2016
- (2016) Markus V. Heppt et al. Oncology Research and Treatment
- Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma
- (2015) Maria Romina Girotti et al. CANCER CELL
- Alternative transcription initiation leads to expression of a novel ALK isoform in cancer
- (2015) Thomas Wiesner et al. NATURE
- Prevalence and Characterization of Murine Leukemia Virus Contamination in Human Cell Lines
- (2015) Cord C. Uphoff et al. PLoS One
- Intercellular Transfer of Cancer Drug Resistance Traits by Extracellular Vesicles
- (2015) Diana Sousa et al. TRENDS IN MOLECULAR MEDICINE
- Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy
- (2015) Zeynep Eroglu et al. Therapeutic Advances in Medical Oncology
- Wild-type ALK and activating ALK-R1275Q and ALK-F1174L mutations upregulate Myc and initiate tumor formation in murine neural crest progenitor cells
- (2015) Gisèle Montavon et al. Oncotarget
- Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles
- (2013) Marina Colombo et al. JOURNAL OF CELL SCIENCE
- Pharmacodynamic Effects and Mechanisms of Resistance to Vemurafenib in Patients With Metastatic Melanoma
- (2013) Kerstin Trunzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Resistance to RAF Inhibitors Revisited
- (2013) Edward Hartsough et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
- (2012) Héctor Peinado et al. NATURE MEDICINE
- Anaplastic lymphoma kinase (ALK): Structure, oncogenic activation, and pharmacological inhibition
- (2012) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of Replication Competent Murine Gammaretroviruses in Commonly Used Prostate Cancer Cell Lines
- (2011) Karen Sandell Sfanos et al. PLoS One
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
- (2008) Isabelle Janoueix-Lerosey et al. NATURE
- Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells
- (2008) Khalid Al-Nedawi et al. NATURE CELL BIOLOGY
- A mouse model for EML4-ALK-positive lung cancer
- (2008) M. Soda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now